All Stories

  1. Racial disparities in antibiotic selection for community-acquired pneumonia in hospitalized patients
  2. Clinical characteristics and risk factors for Clostridioides difficile infection in the hematopoietic cell transplantation population
  3. Implementation of conditional reflex urine culturing decreases unnecessary antimicrobial use
  4. A solution for dysfunctional dilution: real-time detection of malfunctioning automated disinfectant dispensers using colorimetric or hydrophobic wipes that indicate disinfectant concentrations
  5. Assessment of Large Language Model Performance on Medical School Essay-Style Concept Appraisal Questions (Preprint)
  6. Assessment of Large Language Model Performance on Medical School Essay-Style Concept Appraisal Questions: An Exploratory Study (Preprint)
  7. Impact of empiric antibiotics on risk of Clostridioides difficile—a causal inference observational analysis
  8. Acceptance of pharmacist-led stewardship recommendations for patients with community-acquired pneumonia
  9. Meta-analysis of predictors of healthcare-associated Clostridioides difficile infection
  10. Reducing antimicrobial overuse through targeted therapy for patients with community-acquired pneumonia: a study protocol for a cluster-randomized factorial controlled trial (CARE-CAP)
  11. Diagnostic prediction models to identify patients at risk for healthcare-facility–onset Clostridioides difficile: A systematic review of methodology and reporting
  12. Intravenous to Oral Antibiotic Switch Therapy among Patients Hospitalized with Community-Acquired Pneumonia
  13. Derivation and external validation of a prediction model for pneumococcal urinary antigen test positivity in patients with community-acquired pneumonia
  14. Can Electronic Clinical Decision Support Systems Improve the Diagnosis of Urinary Tract Infections? : A Systematic Review and Meta-Analysis
  15. Adoption and Trends in Uptake of Updated ICD-10 Codes for Clostridioides difficile – A Retrospective Observational Study
  16. Derivation and validation of a risk assessment model for drug-resistant pathogens in hospitalized patients with community-acquired pneumonia
  17. Association of fluoroquinolones or cephalosporin plus macrolide with Clostridioides difficile infection (CDI) after treatment for community-acquired pneumonia
  18. Epidemiology and Outcomes of Community-acquired Escherichia coli Pneumonia
  19. Change in individual physicians’ screening mammography completion rates following the updated USPSTF guideline supporting shared decision making: An observational cohort study
  20. Risk factors for Clostridioides difficile colonization among hospitalized adults: A meta-analysis and systematic review
  21. Monitoring the effectiveness of daily cleaning practices in an intensive care unit (ICU) setting using an adenosine triphosphate (ATP) bioluminescence assay
  22. Early Readmissions after Esophagectomy for Esophageal Adenocarcinoma: Does Facility Case-Volume Matter?
  23. Multidrug-resistant organisms on patients hands in an ICU setting
  24. Acute Ischemic Stroke Therapy in Infective Endocarditis: Case Series and Systematic Review
  25. Risk factors for Clostridium difficile infection in pediatric inpatients: A meta-analysis and systematic review
  26. Hospital readmissions related to Clostridium difficile infection in the United States
  27. Comparative Antimicrobial Efficacy of Two Hand Sanitizers in Intensive Care Units Common Areas: A Randomized, Controlled Trial
  28. Are hospital floors an underappreciated reservoir for transmission of health care-associated pathogens?
  29. Diagnostic testing methods for Clostridium difficile infection: A statewide survey of Ohio acute care hospitals
  30. Rising Incidence of Clostridium difficile Related Discharges among Hospitalized Children in the United States
  31. Accuracy of loop-mediated isothermal amplification for the diagnosis of Clostridium difficile infection: a systematic review
  32. Mo1844 Effect of Fidaxomicin on Susceptibility to Intestinal Colonization With Vancomycin-Resistant Enterococci and Klebsiella pneumoniae in Mice
  33. Statin Therapy and Mortality from Sepsis: A Meta-analysis of Randomized Trials
  34. Colonization Versus Carriage of Clostridium difficile
  35. Sustained increase in resident meal time hand hygiene through an interdisciplinary intervention engaging long-term care facility residents and staff
  36. Risk Factors for Recurrent Clostridium difficile Infection: A Systematic Review and Meta-Analysis
  37. Low Incidence of Clostridium difficile Infection (CDI) in Patients Treated with Outpatient Parenteral Antimicrobial Therapy (OPAT)
  38. Clostridium difficile Infection in Hospitalized Patients with Cystic Fibrosis
  39. Evaluation of a Sporicidal Peracetic Acid/Hydrogen Peroxide–Based Daily Disinfectant Cleaner
  40. Metabolomics Analysis Identifies Intestinal Microbiota-Derived Biomarkers of Colonization Resistance in Clindamycin-Treated Mice
  41. Sensitive and Selective Culture Medium for Detection of Environmental Clostridium difficile Isolates without Requirement for Anaerobic Culture Conditions
  42. More Cleaning, Less Screening: Evaluation of the Time Required for Monitoring versus Performing Environmental Cleaning
  43. A Randomized Trial of Soap and Water Hand Wash Versus Alcohol Hand Rub for Removal of Clostridium difficile Spores from Hands of Patients
  44. Pseudo-Outbreak of Klebsiella oxytoca Spontaneous Bacterial Peritonitis Attributed to Contamination of Multidose Vials of Culture Medium Supplement
  45. Efficacy of Dilute Hypochlorite Solutions and an Electrochemically Activated Saline Solution Containing Hypochlorous Acid for Disinfection of Methicillin-Resistant Staphylococcus aureus in a Pig Skin Model
  46. Asymptomatic carriage of toxigenic Clostridium difficile by hospitalized patients
  47. Clostridium difficile Infection in the Hospitalized Pediatric Population
  48. Use of Lactobacillus in Prevention of Recurrences of Clostridium difficile Infection in Solid Organ Transplant Recipients
  49. Evaluation of a commercial real-time polymerase chain reaction assay for detection of environmental contamination with Clostridium difficile
  50. Diagnostic Testing for Clostridium difficile Infection in Patients With Inflammatory Bowel Disease
  51. Vascular endothelial growth factor in the CSF of elderly patients with ventriculomegaly: Variability, periodicity and levels in drainage responders and non-responders
  52. Utility of an Adenosine Triphosphate Bioluminescence Assay to Evaluate Disinfection of Clostridium difficile Isolation Rooms
  53. Outpatient Healthcare Settings and Transmission of Clostridium difficile
  54. Appropriateness of empiric therapy in patients with suspectedClostridium difficileinfection
  55. Clostridium difficile infection in children: a comprehensive review
  56. Deficient Reporting and Interpretation of Non-Inferiority Randomized Clinical Trials in HIV Patients: A Systematic Review
  57. An Environmental Disinfection Odyssey: Evaluation of Sequential Interventions to Improve Disinfection of Clostridium difficile Isolation Rooms
  58. Community-associated Clostridium difficile infection and antibiotics: a meta-analysis
  59. Health Care Burden of Clostridium difficile Infection in Hospitalized Children with Inflammatory Bowel Disease
  60. Potential for Transmission of Spores by Patients Awaiting Laboratory Testing to Confirm Suspected Clostridium difficile Infection
  61. Acid-suppressive therapy is associated with spontaneous bacterial peritonitis in cirrhotic patients: A meta-analysis
  62. Reply
  63. Repeat stool testing for Clostridium difficile using enzyme immunoassay in patients with inflammatory bowel disease increases diagnostic yield
  64. Association ofClostridium difficileinfection with outcomes of hospitalized solid organ transplant recipients: results from the 2009 Nationwide Inpatient Sample database
  65. Valproate-induced hyperammonemic encephalopathy: a brief review
  66. Reply
  67. Increased Rate of Spontaneous Bacterial Peritonitis Among Cirrhotic Patients Receiving Pharmacologic Acid Suppression
  68. Association Between Proton Pump Inhibitor Therapy and Clostridium difficile Infection in a Meta-Analysis
  69. Robotics as a new surgical minimally invasive approach to treatment of endometriosis: a systematic review
  70. Clinical approach to severe Clostridium difficile infection: Update for the hospital practitioner
  71. Diagnostic Accuracy of Real-time Polymerase Chain Reaction in Detection of Clostridium difficile in the Stool Samples of Patients With Suspected Clostridium difficile Infection: A Meta-Analysis
  72. Effect of rural-to-urban within-country migration on cardiovascular risk factors in low- and middle-income countries: a systematic review
  73. Repeat Stool Testing to Diagnose Clostridium difficile Infection Using Enzyme Immunoassay Does Not Increase Diagnostic Yield
  74. Stability Analysis of Vascular Endothelial Growth Factor in Cerebrospinal Fluid
  75. Pulmonary hypertension: An important predictor of outcomes in patients undergoing non-cardiac surgery
  76. Shunting in chronic hydrocephalus induces VEGFR-2 and blood vessel density changes in the caudate nucleus
  77. Potential value of repeat stool testing for Clostridium difficile stool toxin using enzyme immunoassay?
  78. VEGF/VEGFR-2 changes in frontal cortex, choroid plexus, and CSF after chronic obstructive hydrocephalus
  79. Dissociation between Vascular Endothelial Growth Factor Receptor-2 and Blood Vessel Density in the Caudate Nucleus after Chronic Hydrocephalus
  80. Dissociation between Vascular Endothelial Growth Factor Receptor-2 and Blood Vessel Density in the Caudate Nucleus after Chronic Hydrocephalus
  81. Chronic hydrocephalus–induced hypoxia: Increased expression of VEGFR-2+ and blood vessel density in hippocampus
  82. Do fluoroquinolones predispose patients to Clostridium difficile associated disease? A review of the evidence
  83. VEGF-R2+ activation in the caudate: an adaptive angiogenic response to hypoxia in chronic hydrocephalus?
  84. Hydrocephalus-induced ischemia relating to VEGF-R2 and blood vessel density in hippocampus